Atara Biotherapeutics Reports Results for ATA188 in P-II Trial for the Treatment of Non-Active Progressive Multiple Sclerosis
Shots: The P-II (EMBOLD) clinical trial evaluates the safety & efficacy of ATA188 vs PBO in patients (n=103) with non-active progressive multiple sclerosis for duration […]